Tumor-infiltrating mast cells as potential chemoimmunotherapy enhancer in triple-negative breast cancer
Over the past decade, combining immune checkpoint blockade with chemotherapy has reshaped the paradigm of triple-negative breast cancer (TNBC), but the cellular dynamics in the tumor immune microenvironment (TIME) that orchestrate clinical response re…